Surgery Partners (SGRY) PT Lowered to $24 at Benchmark Following Q4 Miss, Conservative Guidance

March 4, 2026 9:41 AM EST Send to a Friend
Benchmark analyst Bill Sutherland lowered the price target on Surgery Partners (NASDAQ: SGRY) to $24.00 (from $30.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login